Study finds no benefit to intensive treatment for early type 2 diabetes

08/24/2011 | Medscape (free registration)

Data on more than 1,500 Danish participants with type 2 diabetes found that those in an intensive treatment group had a 7.3% prevalence of ankle-brachial index of 0.9 or less and 30.1% of participants had abnormal neuropathy results six years after screening, compared with 9.1% and 34.8% respectively in the routine care group. The researchers, writing in Diabetes Care, concluded there was no statistically significant effect of intensive management upon early detection of type 2 diabetes.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park